This inventor holds 9 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: The United States Government as Represented by the Department of Veterans Affairs, University of Arkansas, The University of Texas System. Active years: 2011-2023.
Location History:
- Little Rock, AR (US) (2011)
- San Antonio, TX (US) (2013 - 2023)
Company Filing History:
5 out of 955 
5 out of 849 
3 out of 5,630 
Years Active: 2011-2023
Title: Innovator Spotlight: Xiao-Dong Chen
Introduction
Xiao-Dong Chen is a notable inventor based in San Antonio, TX, who has made significant contributions to the field of regenerative medicine. With an impressive portfolio of nine patents, his work focuses primarily on mesenchymal stem cells and their applications in improving health outcomes for the elderly.
Latest Patents
Among his latest innovations, Chen has developed methods to enrich and amplify highly potent human mesenchymal stem cells from elderly cell populations. His patents include techniques for restoring the regenerative capability of these cells, as well as isolating and expanding less defective mesenchymal stem cells derived from the bone marrow of individuals with decreased quality and quantity of stem cells. Additionally, he has explored various embodiments for maintaining and propagating mammalian mesenchymal stem cells in an undifferentiated state without the use of feeder cells, expanding the potential applications in regenerative therapies.
Career Highlights
Throughout his career, Chen has contributed his expertise to reputable institutions and organizations. He has collaborated with the University of Arkansas and The United States of America as represented by the Department of Veterans Affairs. His work in these esteemed establishments has paved the way for advancements in stem cell research and practical applications in medicine.
Collaborations
Xiao-Dong Chen has worked alongside notable colleagues such as Robert L. Jilka and Chih-Ko Yeh. Their joint efforts in research and development have significantly impacted the understanding and application of mesenchymal stem cells, urging the expansion of this promising field.
Conclusion
Xiao-Dong Chen's innovations in mesenchymal stem cell research hold great promise for enhancing regenerative health, particularly in the aging population. His numerous patents signify a commitment to advancing medical science and improving quality of life through cutting-edge research and applications. As the field of regenerative medicine continues to evolve, contributions from inventors like Chen will undoubtedly play a critical role in shaping the future of healthcare.